United States Brucellosis Vaccines Market Report 2016

United States Brucellosis Vaccines Market Report 2016

1 Brucellosis Vaccines Overview

1.1 Product Overview and Scope of Brucellosis Vaccines

1.2 Classification of Brucellosis Vaccines

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Brucellosis Vaccines

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Brucellosis Vaccines (2011-2021)

1.4.1 USA Brucellosis Vaccines Sales and Growth Rate (2011-2021)

1.4.2 USA Brucellosis Vaccines Revenue and Growth Rate (2011-2021)

2 USA Brucellosis Vaccines Competition by Manufacturers

2.1 USA Brucellosis Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Brucellosis Vaccines Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Brucellosis Vaccines Average Price by Manufactures (2015 and 2016)

2.4 Brucellosis Vaccines Market Competitive Situation and Trends

2.4.1 Brucellosis Vaccines Market Concentration Rate

2.4.2 Brucellosis Vaccines Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Brucellosis Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Brucellosis Vaccines Sales and Market Share by Type (2011-2016)

3.2 USA Brucellosis Vaccines Revenue and Market Share by Type (2011-2016)

3.3 USA Brucellosis Vaccines Price by Type (2011-2016)

3.4 USA Brucellosis Vaccines Sales Growth Rate by Type (2011-2016)

4 USA Brucellosis Vaccines Sales (Volume) by Application (2011-2016)

4.1 USA Brucellosis Vaccines Sales and Market Share by Application (2011-2016)

4.2 USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Brucellosis Vaccines Manufacturers Profiles/Analysis

5.1 Bayer HealthCare AG (Germany)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Brucellosis Vaccines Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Biogenesis-Bago (Argentina)

5.2.2 Brucellosis Vaccines Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Boehringer Ingelheim GmbH (Germany)

5.3.2 Brucellosis Vaccines Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Ceva Sante Animale (France)

5.4.2 Brucellosis Vaccines Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Ceva Sante Animale (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Heska Corporation (US)

5.5.2 Brucellosis Vaccines Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Heska Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Indian Immunologicals Ltd (India)

5.6.2 Brucellosis Vaccines Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Lohmann Animal Health (US)

5.7.2 Brucellosis Vaccines Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Lohmann Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Merck Animal Health (US)

5.8.2 Brucellosis Vaccines Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Merck Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Merial Ltd. (US)

5.9.2 Brucellosis Vaccines Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Merial Ltd. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Protein Sciences Corporation (US)

5.10.2 Brucellosis Vaccines Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Protein Sciences Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Virbac SA (France)

5.12 Zoetis Inc. (US)

6 Brucellosis Vaccines Manufacturing Cost Analysis

6.1 Brucellosis Vaccines Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Brucellosis Vaccines

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Brucellosis Vaccines Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Brucellosis Vaccines Market Forecast (2016-2021)

10.1 USA Brucellosis Vaccines Sales, Revenue Forecast (2016-2021)

10.2 USA Brucellosis Vaccines Sales Forecast by Type (2016-2021)

10.3 USA Brucellosis Vaccines Sales Forecast by Application (2016-2021)

10.4 Brucellosis Vaccines Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Brucellosis Vaccines

Table Classification of Brucellosis Vaccines

Figure USA Sales Market Share of Brucellosis Vaccines by Type in 2015

Table Application of Brucellosis Vaccines

Figure USA Sales Market Share of Brucellosis Vaccines by Application in 2015

Figure USA Brucellosis Vaccines Sales and Growth Rate (2011-2021)

Figure USA Brucellosis Vaccines Revenue and Growth Rate (2011-2021)

Table USA Brucellosis Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Brucellosis Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Brucellosis Vaccines Sales Share by Manufacturers

Figure 2016 Brucellosis Vaccines Sales Share by Manufacturers

Table USA Brucellosis Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Brucellosis Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Brucellosis Vaccines Revenue Share by Manufacturers

Table 2016 USA Brucellosis Vaccines Revenue Share by Manufacturers

Table USA Market Brucellosis Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Brucellosis Vaccines Average Price of Key Manufacturers in 2015

Figure Brucellosis Vaccines Market Share of Top 3 Manufacturers

Figure Brucellosis Vaccines Market Share of Top 5 Manufacturers

Table USA Brucellosis Vaccines Sales by Type (2011-2016)

Table USA Brucellosis Vaccines Sales Share by Type (2011-2016)

Figure USA Brucellosis Vaccines Sales Market Share by Type in 2015

Table USA Brucellosis Vaccines Revenue and Market Share by Type (2011-2016)

Table USA Brucellosis Vaccines Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Brucellosis Vaccines by Type (2011-2016)

Table USA Brucellosis Vaccines Price by Type (2011-2016)

Figure USA Brucellosis Vaccines Sales Growth Rate by Type (2011-2016)

Table USA Brucellosis Vaccines Sales by Application (2011-2016)

Table USA Brucellosis Vaccines Sales Market Share by Application (2011-2016)

Figure USA Brucellosis Vaccines Sales Market Share by Application in 2015

Table USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)

Figure USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)

Table Bayer HealthCare AG (Germany) Basic Information List

Table Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Biogenesis-Bago (Argentina) Basic Information List

Table Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Boehringer Ingelheim GmbH (Germany) Basic Information List

Table Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Ceva Sante Animale (France) Basic Information List

Table Ceva Sante Animale (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ceva Sante Animale (France) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Heska Corporation (US) Basic Information List

Table Heska Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Heska Corporation (US) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Indian Immunologicals Ltd (India) Basic Information List

Table Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Lohmann Animal Health (US) Basic Information List

Table Lohmann Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lohmann Animal Health (US) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Merck Animal Health (US) Basic Information List

Table Merck Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Animal Health (US) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Merial Ltd. (US) Basic Information List

Table Merial Ltd. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merial Ltd. (US) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Protein Sciences Corporation (US) Basic Information List

Table Protein Sciences Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Protein Sciences Corporation (US) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Virbac SA (France) Basic Information List

Table Virbac SA (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Virbac SA (France) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Zoetis Inc. (US) Basic Information List

Table Zoetis Inc. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zoetis Inc. (US) Brucellosis Vaccines Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Brucellosis Vaccines

Figure Manufacturing Process Analysis of Brucellosis Vaccines

Figure Brucellosis Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2015

Table Major Buyers of Brucellosis Vaccines

Table Distributors/Traders List

Figure USA Brucellosis Vaccines Production and Growth Rate Forecast (2016-2021)

Figure USA Brucellosis Vaccines Revenue and Growth Rate Forecast (2016-2021)

Table USA Brucellosis Vaccines Production Forecast by Type (2016-2021)

Table USA Brucellosis Vaccines Consumption Forecast by Application (2016-2021)